Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6848496rdf:typepubmed:Citationlld:pubmed
pubmed-article:6848496lifeskim:mentionsumls-concept:C0031676lld:lifeskim
pubmed-article:6848496lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:6848496lifeskim:mentionsumls-concept:C1705920lld:lifeskim
pubmed-article:6848496lifeskim:mentionsumls-concept:C0205430lld:lifeskim
pubmed-article:6848496lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:6848496pubmed:issue1lld:pubmed
pubmed-article:6848496pubmed:dateCreated1983-2-14lld:pubmed
pubmed-article:6848496pubmed:abstractTextD-beta-Hydroxybutyrate apodehydrogenase is a lipid-requiring enzyme with a specific requirement of lecithin for enzymatic function. The purified enzyme which is devoid of lipid can be reactivated with lecithin or mixtures of natural phospholipid-containing lecithin. However, it is mitochondrial phospholipid which activates the enzyme optimally and with kinetic parameters similar to that of the native membrane-bound enzyme. Mitochondrial phospholipid consists of three classes of phospholipid (lecithin:phosphatidylethanolamine:diphosphatidylglycerol in a ratio of approximately 2:2:1 by phosphorus); each class consists of a multiplicity of different molecular species due to diversity in the fatty acyl substituents. In this study, we have synthesized defined molecular species of mixed fatty acyl phospholipids to evaluate whether multiplicity of phospholipid molecular species are essential for optimal reactivation. We find that: 1) ternary mixtures of single molecular species of phosphatidylcholine, phosphatidylethanolamine, and phosphatidylpropan-1,3-diol in the liquid crystalline state mimic the optimal reactivation of the enzyme obtained with mitochondrial phospholipids; 2) although some negatively charged phospholipid appears necessary for optimizing the efficiency of activation, diphosphatidylglycerol can be replaced by phosphatidylpropan-1,3-diol, another negatively charged phospholipid; and 3) biphasic Arrhenius plots can be correlated with the liquid crystalline and gel states of the phospholipid.lld:pubmed
pubmed-article:6848496pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6848496pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6848496pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6848496pubmed:languageenglld:pubmed
pubmed-article:6848496pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6848496pubmed:citationSubsetIMlld:pubmed
pubmed-article:6848496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6848496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6848496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6848496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6848496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6848496pubmed:statusMEDLINElld:pubmed
pubmed-article:6848496pubmed:monthJanlld:pubmed
pubmed-article:6848496pubmed:issn0021-9258lld:pubmed
pubmed-article:6848496pubmed:authorpubmed-author:FleischerSSlld:pubmed
pubmed-article:6848496pubmed:authorpubmed-author:EiblHHlld:pubmed
pubmed-article:6848496pubmed:authorpubmed-author:ChurchillPPlld:pubmed
pubmed-article:6848496pubmed:authorpubmed-author:McIntyreJ OJOlld:pubmed
pubmed-article:6848496pubmed:issnTypePrintlld:pubmed
pubmed-article:6848496pubmed:day10lld:pubmed
pubmed-article:6848496pubmed:volume258lld:pubmed
pubmed-article:6848496pubmed:ownerNLMlld:pubmed
pubmed-article:6848496pubmed:authorsCompleteYlld:pubmed
pubmed-article:6848496pubmed:pagination208-14lld:pubmed
pubmed-article:6848496pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:meshHeadingpubmed-meshheading:6848496-...lld:pubmed
pubmed-article:6848496pubmed:year1983lld:pubmed
pubmed-article:6848496pubmed:articleTitleActivation of D-beta-hydroxybutyrate apodehydrogenase using molecular species of mixed fatty acyl phospholipids.lld:pubmed
pubmed-article:6848496pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6848496pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6848496pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6848496lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6848496lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6848496lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6848496lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6848496lld:pubmed